CVS Health (CVS) was also reported to have shown interest in buying some of the WBA-RAD stores in areas where they don’t compete with existing CVS stores. Purchasing these stores would increase CVS’s footprint in locations where the company doesn’t have a higher market share. However, as per the CTFN report, CVS has already withdrawn its interest.
ETF investors seeking to add exposure to WBA can consider the VanEck Vectors Retail ETF (RTH), which invests 5.1% of its portfolio in WBA.
View more information: https://marketrealist.com/2016/11/will-the-wba-rad-deal-clear-ftc-hurdles/